Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

The Effect of the Compound of Tomato Extract to the Prostatic Cancer Cell and the Prostate of the Rat Model of Benign Prostatic Hyperplasia

토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향

  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Benign prostatic hyperplasia (BPH) is one of the common disease in elderly men. Recently old-age population is increased and we are growing more and more interested in clinical importance of BPH. In this study, the effect of PLX, which was the mixture of tomato extract (including 2% of lycopene) and chitooligosaccharide, on prostatic cancer cell and testosterone-induced BPH in adult rats of the Sprague Dawley strain was determined. The cell viability was evaluated by MTT method using L929 and LNCaP cell line, pretreated with various concentrations of PLX. The expression of prostatic specific antigen (PSA) and 5${\alpha$}$-reductase genes were evaluated by realtime PCR using LNCaP cell line and compared various concentrations of PLX with 50 ${\mu}$M of finasteride. An experimental prostatic hyperplasia was induced in male Sprague Dawley rats by giving testosterone for 8 weeks. After 2 weeks from start of giving testosterone, PLX and finasteride were administered orally once a day. The results were analyzed with prostate weight per body weight at 8 weeks. Cell viability of L929 cell line decreased specifically at the concentration of 2000 ${\mu}$g/mf of PLX. The cytotoxicity of PLX to the LNCaP cell line was shown at above 500 ${\mu}$g/ml of PLX. The inhibitory effect of PLX to the expression of PSA and 5${\alpha$}$-reductase genes in LNCaP cell line increased with the concentration of PLX. In vivo study, the results of PLX and finasteride administered group were 3.75${\pm}$0.60 and 3.49${\pm}$0.49 prostate weight ${\times}10^3$/body weight, which were lower than the result of BPH induced group (4.74${\pm}$0.58). These results suggested that PLX may be an effective material in BPH by having the role of the 5a-reductase inhibitor.

Keywords

References

  1. Rhoehrborn, C. G., Marks, L., Harkaway, R. (2006) Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners. Prostate Cancer Prostatic Dis 9: 30-34 https://doi.org/10.1038/sj.pcan.4500841
  2. AUA Practice Guidelines Committee. (2003) AUA guideline on management of benign prostatic hyperplasia, Chapter 1: Diagnosis and treatment recommendations. J Urol 170: 530-547 https://doi.org/10.1097/01.ju.0000078083.38675.79
  3. Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., Hobbs, S. (2004) Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5$\alpha$-reductase inhibitior. J Clin Endocrinol Metab 89: 2179-2184 https://doi.org/10.1210/jc.2003-030330
  4. Isaacs, J. T. (1984) Antagonistic effect of androgen on prostatic cell death. Prostate 5: 545-557 https://doi.org/10.1002/pros.2990050510
  5. Nixon, P. (1997) New clinical trial of medical therapy for benign prostatic hyperplasia. Drug Benefit Trends 9: 44-45
  6. Bonkhoff, H., Stein, U., Aumuller, G., Remberger, K. (1996) Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas. Prostate 29: 261-267 https://doi.org/10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO;2-E
  7. Lehle, C., Radvanyi, F., Gil Diez de Medina, S. (1999) Differences in steroid 5 alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue. J Steroid Biochem Mol Biol 68: 189-195 https://doi.org/10.1016/S0960-0760(99)00030-8
  8. Silver, R. I., Wiley, E. L., Davis, D. L., Thigpen, A. E., Russell, D. W., McConnell, J. D. (1994) Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease. J Urol 152: 433-437 https://doi.org/10.1016/S0022-5347(17)32757-X
  9. Di Silverio, F., Flammia, G. P., Sciarra, A. (1993) Plant extracts in benign prostatic hyperplasia, Minerva Urol Nefrol 45: 143-149
  10. Buck, A. C. (1996) Phytotherapy for the prostate. Br J Urol 78: 325-326 https://doi.org/10.1046/j.1464-410X.1996.00104.x
  11. Bales, G. T., Christiano, A. P., Kirsh, E. J., Gerber, G. S. (1999) Phytotherapeutic agents in the treatment of lower urinary track symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology 54: 86-89 https://doi.org/10.1016/S0090-4295(99)00028-X
  12. Wilt, T. J., MacDonald, R., Ishani, A. (1999) Beta-sisterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU International 83: 976-983 https://doi.org/10.1046/j.1464-410x.1999.00026.x
  13. Wilt, T. J., Ishani, A., Stark, G. (1998) Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 280: 1604-1609 https://doi.org/10.1001/jama.280.18.1604
  14. Pannala, A. S., Rice-Evans, C., Sampson, J., Sin, S. (1998) Interaction of peroxynitrite with carotenoids and tocopherols within low density lipoprotein. FEBS Letters 423: 297-301 https://doi.org/10.1016/S0014-5793(98)00108-2
  15. Xing, N., Chen, Y., Mitchell, S. H., Young, C. V. (2001) Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 22: 409-414 https://doi.org/10.1093/carcin/22.3.409
  16. Friendman, M. (2002) Tomato glycoalkaloids: role in the plant and in the diet. J Agric Food Chem 50: 5751-5760 https://doi.org/10.1021/jf020560c
  17. Giovannucci, E., Rimm, E. B., Liu, Y., Stampfer, M. J., Willett, W. C. (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94: 391-398 https://doi.org/10.1093/jnci/94.5.391
  18. Siler, U., Barella, L., Spitzer, V., Schnorr, J., Lein, M., Goralczyk, R., Wertz, K. (2004) Lycopene and vitamin E interfere with autocrine/paracrine loops in the dunning prostate cancer model. FASEB J 14: 1-23
  19. Jameela, S. R., Misra, A., Jayakrishnan, A. (1994) Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomater Sci Polym Ed 6: 621-632 https://doi.org/10.1163/156856294X00563
  20. Okamoto, Y., Inoue, A., Miyatake, K., Ogihara, K., Shigemasa, Y., Minami, S. (2003) Effects of chitin/shitosan and their oligomers/monomers on migrations of macrophages. Macromol Biosci 3: 587-590 https://doi.org/10.1002/mabi.200350026
  21. Gerasimenko, D. V., Avdienko, I. D., Bannikova, G. E., Zueva, O. Y., Varlamov, V. P. (2004) Antibacterial effects of water-soluble low-molecular-weight chitosans on different microorganisms. Appl Biochem Microbiol 40: 253-257 https://doi.org/10.1023/B:ABIM.0000025947.84650.b4
  22. Tokoro, A., Tatewaki, N., Suzuki, K., Mikami, T., Suzuki, S., Suzuki, M. (1998) Growth inhibitory effect of hexa-N-acetylchitohexaose and chitohexaos and Meth-A solid tumor. Chem Pharm Bull 36: 784-790
  23. Jeon, T. I., Hwang, S. G., Park, N. G., Jung, Y. R., Shin, S. I., Choi, S. D., Park, D. K. (2003) Antioxidative effect of chitosan on chronic carbon tetrachloride induced hepatic injury in rats. Toxicology 187: 67-73 https://doi.org/10.1016/S0300-483X(03)00003-9
  24. Di Mascio, P., Kaiser, S., Sies, H. (1989) Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Soc Trans 24: 1023-1027
  25. Kotakanara, E., Kushiro, M., Zhang, H., Sugawara, T., Myashita, K., Nagao, A. (2001) Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131: 3303-3306
  26. Berry, S. J., Coffey, D. S., Strandberg, J. D., Ewing, L. L. (1986) Effect of age, castration and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia. Prostate 9: 295-302 https://doi.org/10.1002/pros.2990090308
  27. Karr, J. P., Kim, U., Resko, J. A., Schneider, S., Chai, L. S., Murphy, G. P., Sandbery, A. A. (1984) Induction of benign prostatic hypertrophy in baboons. Urology 23: 276-289 https://doi.org/10.1016/S0090-4295(84)90047-5
  28. Schroeder, F. H. (1983) Current models and their relation to human diseases. In Hinman, F. (ed.), Benign prostatic hypertophy, 215-228. Springer Verlag, New York, USA
  29. Coffey, D. S., Walsh, P. C. (1990) Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 17: 461-475
  30. Constantinou, C. E. (1996) Influence of hormone treatment on prostate growth and micturition characteristics of the rat. Prostate 26: 30-35